Neuropsychological features of mild cognitive impairment and preclinical Alzheimer's disease
about
sameAs
Impaired cross-modal inhibition in Alzheimer diseaseAutoimmune manifestations in the 3xTg-AD model of Alzheimer's disease.The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychologic test battery.Brain substrates of learning and retention in mild cognitive impairment diagnosis and progression to Alzheimer's diseaseGroup-Level Progressive Alterations in Brain Connectivity Patterns Revealed by Diffusion-Tensor Brain Networks across Severity Stages in Alzheimer's Disease.Potential therapeutic strategies for Alzheimer's disease targeting or beyond β-amyloid: insights from clinical trialsSoybean-derived phosphatidylserine improves memory function of the elderly Japanese subjects with memory complaints.The epidemiology of mild cognitive impairment (MCI) and Alzheimer's disease (AD) in community-living seniors: protocol of the MemoVie cohort study, Luxembourg.Hierarchical cognitive and psychosocial predictors of amnestic mild cognitive impairmentNT-020, a natural therapeutic approach to optimize spatial memory performance and increase neural progenitor cell proliferation and decrease inflammation in the aged rat.A pilot study on utility of Malayalam version of Addenbrooke's Cognitive Examination in detection of amnestic mild cognitive impairment: A critical insight into utility of learning and recall measures.Clinical features and multidisciplinary approaches to dementia care.Differential memory test sensitivity for diagnosing amnestic mild cognitive impairment and predicting conversion to Alzheimer's disease.Occipital sources of resting-state alpha rhythms are related to local gray matter density in subjects with amnesic mild cognitive impairment and Alzheimer's diseaseElectrophysiological correlates of amnestic mild cognitive impairment in a simon task.The Chinese version of story recall: a useful screening tool for mild cognitive impairment and Alzheimer's disease in the elderlyNeuroplastic effects of combined computerized physical and cognitive training in elderly individuals at risk for dementia: an eLORETA controlled study on resting states.Imaging biomarkers for treatment development for impaired cognition: report of the sixth CNTRICS meeting: Biomarkers recommended for further development.Paroxysmal atrial fibrillation and the hazards of under-treatmentSelective Ability of Some CANTAB Battery Test Measures to Detect Cognitive Response to a Single Dose of Donepezil in Alzheimer Disease.Clinical trials in mild cognitive impairment: lessons for the future.Discriminative and predictive power of an informant report in mild cognitive impairmentIs the Alzheimer's disease cortical thickness signature a biological marker for memory?Defining MCI in the Framingham Heart Study Offspring: education versus WRAT-based norms.Efficacy of cognitive rehabilitation therapies for mild cognitive impairment (MCI) in older adults: working toward a theoretical model and evidence-based interventions.Level of recall, retrieval speed, and variability on the Cued-Recall Retrieval Speed Task (CRRST) in individuals with amnestic mild cognitive impairment.Multiple cognitive deficits in amnestic mild cognitive impairment.Towards a cognitive stimulation program using an errorless learning paradigm in amnestic mild cognitive impairment.The Memory and Aging Telephone Screen: development and preliminary validation.Neuropsychological indicators of preclinical Alzheimer's disease among depressed older adults.Specific Features of Executive Dysfunction in Alzheimer-Type Mild Dementia Based on Computerized Cambridge Neuropsychological Test Automated Battery (CANTAB) Test Results.Electroencephalographic rhythms in Alzheimer's disease.Comparison of performance in neuropsychological tests in amnestic Mild Cognitive Impairment and Alzheimer's disease patients.Study on the Behavioural Assessment of the Dysexecutive Syndrome (BADS) performance in healthy individuals, Mild Cognitive Impairment and Alzheimer's disease: A preliminary study.Disrupted functional connectivity between perirhinal and parahippocampal cortices with hippocampal subfields in patients with mild cognitive impairment and Alzheimer's disease.Establishment of an Alzheimer's disease model with latent herpesvirus infection using PS2 and Tg2576 double transgenic mice.Hypothesis: apo-lactoferrin-Galantamine Proteo-alkaloid Conjugate for Alzheimer's disease Intervention.The Default Mode Network Supports Episodic Memory in Cognitively Unimpaired Elderly Individuals: Different Contributions to Immediate Recall and Delayed Recall.A novel method of early diagnosis of Alzheimer's disease based on EEG signals.
P2860
Q24815142-F18A17E0-A99A-4AC0-98C2-ACE274534BEBQ30415876-56361E68-C71C-48E7-BA81-68A2AC258F96Q33454243-C132DD1E-B025-461C-AAC1-2A85CBB07C6EQ33776799-C0425E64-4077-4750-880E-428AADAAF018Q33881832-94F3FE7A-8125-42BB-9CE3-50D731AE73A0Q34014237-500A6237-0313-452B-BC21-AD54981FC4F4Q34255281-9A306392-FBC5-43F2-BFDB-6E6C6C6A65CFQ34334180-044CD406-9D4A-4E47-A5BC-1A2F7EEF7206Q34420681-9FB7662A-4D6F-4839-BAB2-A432B3835245Q34460975-C37510EE-B310-4FF2-82BC-0CC15AC81BCBQ34606859-9948E31B-CA01-44D6-8AAE-CB2E3E247DC3Q35015449-A73A0DDF-D9A2-4300-A5F1-9747CE723760Q35043616-457B7606-A366-4301-A9BC-40F258008B48Q35044402-54727293-78DD-40AE-9638-D54CEB1B0669Q35067544-4DBF7446-CF74-404A-86C2-1925ABECBF2CQ35115674-82AAFDEE-8B74-4B06-AA18-CBC490C6D0C3Q35512038-E7183416-E311-4D37-9251-36B450CEEEDAQ35632516-2AA5D560-83AC-4E70-B632-1E4E0BD3CB31Q35784686-101C9042-A09F-4ED9-8DF1-097D2938C688Q36036556-F00EED1A-C25C-43FF-8088-8F34F18422ABQ36142255-8985FF4D-BF66-4F8E-BD80-533957596250Q36142635-CAB0C10D-C078-4576-8F8D-400747EA703AQ36348325-554CDA7C-2C7D-406A-9557-BCE992597D05Q36767137-28F1549A-3CDD-41CD-8A19-3ABBA640B416Q36807552-B6B339B2-B9D9-4892-9D9E-C22394165FA8Q36918600-9FAD4CBD-763C-4054-AC3C-E7F0F2D220D9Q37073649-3A7F795F-16B1-48A5-9D72-ACC6DD694720Q37129877-C42C7865-023C-40E0-84D8-D05AA253321AQ37267578-4C3A1D92-C792-4892-8D59-40D2802B8E00Q37333228-CF19599F-3FA8-4564-90A2-D2A2E54166D8Q37337804-B0A4571F-EDCB-4B72-B3C0-265A1BD49481Q37883098-10BE6AF1-ACF4-461D-9DC2-1611646B4435Q45933281-2720147E-CE20-4ECD-98FB-2D95DC4B22A3Q47134812-E51A0843-03F4-4E28-9785-7A4576720816Q47260966-A0B2204C-7F0B-4274-B0D6-BB3C6766D31EQ47571428-CBB8D585-6932-4641-A2D7-31B1185838DAQ47834807-1F293966-4F45-4071-8FCA-5B2B8423BC9CQ49165138-787F7D1D-D674-4323-9E2D-F80B27E64FBEQ53473500-D549ACBA-1C92-409F-AAC6-708B52D6C478
P2860
Neuropsychological features of mild cognitive impairment and preclinical Alzheimer's disease
description
2003 nî lūn-bûn
@nan
2003 թուականին հրատարակուած գիտական յօդուած
@hyw
2003 թվականին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Neuropsychological features of ...... reclinical Alzheimer's disease
@ast
Neuropsychological features of ...... reclinical Alzheimer's disease
@en
Neuropsychological features of ...... reclinical Alzheimer's disease
@nl
type
label
Neuropsychological features of ...... reclinical Alzheimer's disease
@ast
Neuropsychological features of ...... reclinical Alzheimer's disease
@en
Neuropsychological features of ...... reclinical Alzheimer's disease
@nl
prefLabel
Neuropsychological features of ...... reclinical Alzheimer's disease
@ast
Neuropsychological features of ...... reclinical Alzheimer's disease
@en
Neuropsychological features of ...... reclinical Alzheimer's disease
@nl
P1476
Neuropsychological features of ...... reclinical Alzheimer's disease
@en
P2093
Eva Arnáiz
P407
P50
P577
2003-01-01T00:00:00Z